Kendall Square
Cambridge, MA

A feasibility study to consolidate a pharma giant.
Creating a strategy to optimize their newest building while maximizing the remaining buildings in their campus.
This study saw building 585 developed into test-fit level programming, and an allocation of lab groups across the client’s entire portfolio.
Key concepts included vertical connectivity, community driven space planning, and strategic programming adjacencies.